Olema Pharmaceuticals, Inc.
OLMA
$5.59
-$0.17-2.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.11% | 1.88% | -25.38% | -60.71% | -51.19% |
| Total Depreciation and Amortization | 40.43% | 45.45% | 31.82% | 5.56% | -5.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.48% | -9.78% | 107.61% | 20.51% | 12.32% |
| Change in Net Operating Assets | 1,066.15% | -458.32% | -62.51% | 177.11% | 80.31% |
| Cash from Operations | -8.45% | -87.18% | -42.26% | -18.78% | -24.59% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 802.67% | -125.52% | -270.12% | 280.43% | -134.52% |
| Cash from Investing | 801.80% | -123.80% | -270.12% | 280.53% | -134.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.71% | -97.37% | 88,521.20% | -99.93% | 663.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 91.57% | -2,807.50% | 100.00% | -- |
| Cash from Financing | -116.14% | -97.48% | 46,611.28% | -99.93% | 663.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.89% | -155.15% | 311.98% | -76.96% | -182.35% |